Use of Dexmedetomidine and Opioids in Hospitalized Preterm Infants
IMPORTANCE: Dexmedetomidine, an α(2)-adrenergic agonist, is not approved by the Food and Drug Administration for use in premature infants. However, the off-label use of dexmedetomidine in premature infants has increased 50-fold in the past decade. Currently, there are no large studies characterizing...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625033/ https://www.ncbi.nlm.nih.gov/pubmed/37921767 http://dx.doi.org/10.1001/jamanetworkopen.2023.41033 |